Redeye leaves a comment following Magle’s recent announcement of a directed share issue of approxima...
Verve Group is emerging as a strong adtech player, with particular strength in mobile and growing po...
Redeye comments on the positive news that Emcitate has received a positive CHMP opinion for MCT8 def...
Biovica records another quarter of modest quarterly IVD test sales growth of 50-55% (compared with t...
Redeye comments on the recently announced USD155m fundraising by Ayar Labs, a key partner of Sivers ...
Redeye comments on today’s news, where Nitro Games continues to demonstrate its strategy of being a ...
Redeye was not surprised to see that Powercell last night carried out a directed share issue of SEK1...
Biovica records IVD test sales in Q2 of SEK 0.97m , which is 54% above the previous quarter (Q1) and...
The company downgraded its full year 2024 net sales guidance midpoint by 4% and EBIT guidance midpoi...
Redeye updates its estimates for 2025 after the partnership announcement with the South Korean free-...
Aspo downgraded guidance as ESL’s demand hasn’t picked up as fast as might have been expected earlie...
Redeye comments on the press release from Moberg Pharma last night.
The somewhat weak Q3 situation continues in Q4 2024.
Redeye gives a short comment on today’s news that Curasight’s TO2 program yielded DKK5.
Aspo downgraded its full year EBITA guidance to EUR ~30m (previously over EUR 32m).
After market close on 9 December, Husqvarna issued a profit warning due to challenging market condit...
Gapwaves has received an order from a new North American Tier-1 for Gapwaves MLW waveguide antenna i...
Tangiamo Touch Technology (”Tangiamo” eller ”bolaget”) meddelade den 6 december 2024 att bolaget har...
- Strong momentum and long runway for growth highlighted - Military modernisation and market share g...
Redeye is encouraged by Climeon's sale of one HP300 unit to NovaAlgoma Cement Carriers that was anno...
